Dear Friends and Colleagues,

On behalf of Keloid Research Foundation; we are delighted to extend a warm welcome, and cordially invite you to join us for the 2nd International Keloid Symposium to be held in the historic City of Rome on June 7-8, 2018 where we can share our knowledge with you; and learn from your experience in treating patients with this very challenging condition. 

The Program Committee has organized an extraordinary array of original clinical as well as basic science sessions for this meeting.  The 2018 program emphasizes exceptionally strong scientific and clinical content across the breadth of Keloid Disorder, from cutting-edge laboratory research and clinical data-mining to current treatment approaches, pros and cons of surgery, radiation therapy, cryotherapy, chemotherapy, laser treatment and other non-surgical interventions.  One session is even dedicated to the discussion of terminology used to describe the disorder, hoping to part from terms such as “Keloid and Hypertrophic Scarring”.  Another session will focus on staging of keloid disorder and it clinical applications as well as analysis of data on >1,000 keloid patients staged accordingly.

This year’s meeting will be a truly international event. As of May 16, 2018, we have participants from Australia, Belgium, Canada, China, France, Greece, Holland, India, Iran, Israel, Italy, Japan, Kenya, New Zealand, Saudi Arabia, Serbia, Singapore, South Africa, South Korea, Switzerland, Tunisia, United Arab Emirates, United Kingdom and the United States. We sincerely hope that all those who participate in our meeting be able to establish connection with other like-minded scientists – with the hope for advancing the research and drug development efforts in this hard to treat disorder.

We hope that this meeting would bring many investigators as well as specialist clinicians, dermatologists, plastic surgeons, ENT physicians, all under one roof to discuss the challenges of this poorly understood and under-studied human ailment for the benefit of those who suffer the most, the keloid patients.

This year’s meeting will be held in conjunction with the joint congress of the International Society of Dermatologic Surgery (ISDS) and the Italian Society of Surgical and Oncological Dermatology (SIDCO).  Registered participants will have full access to all sessions of this collaborative meeting on both days.  Participants who wish to attend the 3rd and 4th days of the SIDCO/ISDS, will need to register for those two days directly with SIDCO/ISDS.   We will soon have a link to this special registration path. 

We look forward to welcoming all of you in Rome.


The Organizing Committee